Multi-center, randomized, placebo-controlled, double blind study of the nitric oxide synthase inhibitor 546c88: Effect on survival in patients with septic shock

1. Grover, R.
2. Lopez, A.
3. Lorente, J.
4. Steingrub, J.
5. Bakker, J.
6. Willatts, S.
7. McLuckie, A.
8. Takala, J.